Early postnatal morbidity and mortality of mammalian neonates represent significant challenges to the agricultural and medical sciences. While many stressors come to bear on the neonate soon after birth, it is convincingly clear that gastrointestinal maladies are among the most prominent. This is not surprising given the relatively quiescent state of the intestine in utero and the rapid ontogeny required following birth. Furthermore, the intestinal mucosa, initially sterile, must be protected from viral and bacterial pathogens that are ubiquitous in the postnatal environment. Because the intestine is a "supply organ", the overall systemic health and vitality of the neonate hinges on its development and function. Therefore, understanding the role of various nutritional, hormonal and pharmacologic agents in ushering the growth, development and function of the intestine is seminal. Our studies have specifically examined rotaviral gastroenteritis, a leading cause of neonatal intestinal injury and diarrhea, with the ultimate goal of improving the rate and extent of recovery. Using rotaviral infection within a neonatal piglet model, we have shown that the level of enteral nutrition delivered postinfection can starkly affect the clinical, biochemical and immunological response during recovery. While a brief period of "gut rest" may be beneficial, if prolonged, it can significantly delay recovery. We also have documented a modest mitogenic response of damaged intestine to supplemental epidermal growth factor, and have shown attenuation of rotaviral damage to the intestine of pigs fed milk replacer formulated with plasma proteins compared with soy-protein-based formulas. However, we have been unable to measure beneficial effects of enteral glutamine or alanyl-glutamine. Our collective findings suggest several positive (but modest) effects of various enteral-treatment regimens/agents on intestinal recovery. Further research is needed to understand better the complex interplay between nutrients, growth factors, immunological, and bacterial determinants which impact intestinal health and ultimately neonatal vitality. Nutrient requirements of preruminant dairy calves are not well described. Current practices, often favoring a least cost approach, may compromise growth performance and health. The present study evaluated and compared immune function in neonatal calves on a higher nutritional plane with that of calves fed a diet meeting current industry standards. Colostrum-fed, Holstein bull calves (n=19) were assigned randomly at ∼4 d of age to one of two treatment groups. Treatment (TRT) 1 calves were fed a 20% crude protein (CP): 20% fat milk replacer (MP) at a rate of 1.4% BW of dry matter (DM)/d for 8 wk. Calves assigned to TRT 2 were fed a 30% CP: 20% fat MR at a rate of 2.4% BW of DM/d. The functional capacity of mononuclear (MNL) populations from peripheral blood collected at 0, 4, 6, and 8 wk during the study period was estimated using a battery of in vitro tests. Nitric oxide (NO) and interferon-γ production by mitogen-stimulated MNL were influenced (P≤.05) by nutritional plane, whereas mitogen-induced DNA-synthesis and secretion of tumor necrosis factor-α and polyclonal immunoglobulin were unaffected (P≥.05). The total number of peripheral blood leukocytes was also unaffected by nutritional plane. These results suggest that increased dietary energy and protein can modulate specific aspects of the neonatal immune system. Additional research is necessary to determine if these changes reflect increased immunocompetency (i.e. infectious disease resistance). Leukocytes from all calves demonstrated age-related changes in their capacity to produce IgM, both cytokines, and NO and to synthesize DNA, possibly reflecting the maturation of the calf's immune system. Leptin is an adipocyte-derived protein that regulates appetite and energy homeostasis. Leptin acts via binding and activation of LR; longform LR predominate in the hypothalamus and are credited with the regulation of appetite control. Short form LR are found in most tissues, and in vitro studies implicate them in the regulation of peripheral tissue metabolism. In rodents, leptin has been implicated in regulating anorexia associated with acute inflammation. As it is not known how the expression of leptin and its receptors are regulated with chronic inflammation in swine, our aim was to determine the effect of serial inflammatory challenges on leptin and LR gene expression in adipose tissue and circulating leptin concentrations. Gilts and barrows (initial body weight ∼ 65 kg) were assigned to Control (saline; gilts n=14, barrows n=12) or lipopolysaccharide (LPS; gilts n=11, barrows n=13) treatments. Animals were injected IM every 7 d for a total of 5 injections. The initial LPS dose was 15 µg/kg BW; dosage was increased 50% each 7d. Blood samples were collected at -24 and +6 hr relative to the 5th LPS injection and at slaughter. Animals were slaughtered ∼60 hr following the final injection. LPS reduced feed intake in barrows and gilts acutely (24 hr post-injection; P<0.01) and chronically (28 days; P<0.05). Leptin mRNA abundance in adipose tissue and serum leptin were not affected by LPS in either sex (P>0.05). However, chronic LPS treatment caused a dramatic reduction in LR expression in adipose tissue of gilts (70%, P<0.002) and barrows (81%, P< 0.01) compared to controls. As leptin is thought to regulate its own expression in adipose tissue as well as to regulate insulin action in the adipocyte, down-regulation of LR with chronic inflammation may have important implications for adipose tissue metabolism and whole-body energy homeostasis. Thyroid status is compromised in a variety of acute and chronic infections and contributes to the impaired growth performance observed during disease states. To simulate and assess the impact of low level disease stress on the coordinated response of the thyroid regulatory/response axis, graded levels of LPS challenge (0, .2, 1.0, 3.0 µg/kg BW, i.v. bolus, E. coli 055:B5) were administered to experimental animals. Two heifers and 14 steers (Angus x Hereford, 243 ± 4 kg) were assigned to control or one of the three levels of LPS treatment (n = 4) and were limit-fed an all-concentrate diet (15% CP, 3.08 Mcal/kg DM) for 5 wk to gain 1.25 kg BW/d. Saline or LPS were injected through the jugular vein and blood samples were collected at 0, 3, 6, 12, 24, and 48 h relative to injection. Liver biopsy samples were obtained 8 h after LPS injection. LPS did not affect plasma concentrations of thyrotropin (TSH) within 12 h after the challenge. After 24 h, TSH was higher, compared to controls, only in animals injected with 3 µg LPS/kg (P < .05). All LPS doses decreased (P < .01) plasma thyroxine (T4) and triiodothyronine (T3) at 6, 12, and 24 h. Negative response of T3, measured as area under the time x concentration curve (AUC), increased linearly with the log of LPS dose (r 2 = .998, P < .05). Plasma reverse-T3 (rT3) increased after all LPS doses at 6 and 12 h (P < .01) and after 1 and 3 µg dose at 24 h; the response in plasma rT3 (AUC) increased linearly with the log of LPS dose (r 2 = .999, P < .05). Hepatic type-I 5'-deiodinase (5'D)
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The principle objective of this study was to examine for relationships between serum IGF-I and growth during the first 90 days of life in Holstein calves. Potentially explanatory or confounding variables included in these models were serum IgG, total protein (TP) or packed cell volume (PCV) at birth, gender, twin status, bovine leukocyte adhesion deficiency (BLAD), serum Zn and Cu. Holstein calves (n = 421) were fed colostrum and brought to a calf facility where measurements of weight, length, and height were recorded at birth, 30, 60, and 90 days. Jugular blood was drawn from calves on day 1 to determine PCV, TP, IgG, Zn, Cu, IGF-I, and BLAD genotype (homozygous negative for the D128G CD18 allele compared to the heterozygous condition). Jugular blood was also drawn on days 2 through 10, 30, 60, and 90 days to determine serum Zn, Cu, and IGF-I (predictor variables). Serum IGF-1 approximately doubled from birth (15 ng/ml) to 90 days (30 ng/ml) in bulls and heifers, with bulls having approximately 20% more circulating IGF-1 than heifers by 90 days of age. Consistently, twins had less circulating IGF-1 than singletons. Serum Zn decreased and Cu increased from birth to 90 days (1.2 to 1.0 ppm Zn and 0.5 to 0.7 ppm Cu). Stepwise multiple regression and logistic regression were used to examine the relationships between predictor variables and weight, height, and length at 30, 60, and 90 days of life. Higher birth weight, single male calves, higher serum IGF-I and Zn, and lower serum Cu and Cu to Zn ratio were positively associated with weight, length, and height (P<0.05). Birth weight was the most important predictor of calf growth. BLAD status did not significantly affect growth in this study. These results suggest that low birth weight, lower serum IGF-I, and inflammation are significantly associated with poor growth (birth to day 90) in neonatal Holstein dairy calves.
Key Words: IGF-1, Zinc/Copper, Inflammation
581
Infection of weaned pigs with Salmonella typhimurium alters plasma insulin-like growth factor binding proteins. J. E. Minton 1 , S. K. Durham* 2 , R. Balaji 1 , and S. S. We demonstrated previously that infection of weaned pigs with S. typhimurium resulted in a suppression of circulating insulin-like growth factor-I (IGF-I). Plasma IGF-I was decreased by 24 h, and was maximally suppressed by 48 h following infectious challenge. Normally, IGF-I circulates primarily as a part of a ternary complex bound to IGF binding protein-3 (IGFBP-3) and the acid labile subunit. Thus, the fall in plasma IGF-I we have observed in diseased pigs may be associated with alterations in circulating concentrations of IGFBPs. The objective of the current investigation was to evaluate concentrations of the IGFBPs, primarily IGFBP-3, in plasma of pigs infected orally with S. typhimurium (S). Pigs were penned individually with ad libitium access to feed and water. After an acclimation period, venous catheters were placed in all animals. Pigs were given sterile broth (C; n = 4) or 3 X 10 9 cfu S (n = 6) in 5 ml broth. Plasma was collected at 24 and 48 h after disease challenge. Plasma was subjected to western ligand blotting (WLB) utilizing 125 I-IGF-I and IGF-II. Images were evaluated for total IGFBPs by densitometric analysis. In addition, plasma samples were analyzed for content of IGFBP-3 utilizing an immunoradiometric assay (IRMA) developed for human IGFBPs. Total IGFBPs were similar between C and S treatments at 24 h, but were reduced (P < .01) in infected pigs at 48 h. Concentrations of IGFBP-3, as estimated by the IRMA, were similar between S and C treatments at 24 h, but tended to be reduced (P < .08) at 48 h in S (217 + 45.8 vs 365.5 + 56.2 ng/mL). The data suggest that reduced circulating IGF-I provoked by enteric disease is accompanied by changes in peripheral IGFBPs, including IGFBP-3.
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Effects of endophyte-infected fescue seed on calf performance and physiological indices. C. Golden*, M. Nihsen, S. Wright, M. Poole, T. Denard, E. Piper, and C. Rosenkrans, Jr., University of Arkansas, Fayetteville.
Cattle consuming endophyte-infected tall fescue (EIF) have reduced productivity. That production loss is reportedly exacerbated by heat stress and bacterial challenge. Our objective was to investigate the interactions between EIF seed on calf feed consumption, weight gain and hematology. Dairy crossbred calves (n = 20; 91 SE 14 kg) were assigned to dietary treatments within a 2x2 factorial design. Treatments were inclusion of non-EIF or EIF seed at 10% of total feed ration. On day 14, five calves were randomly selected from each dietary treatment to undergo stress (intraperitoneal injection of lipopolysaccaride Salmonella typhimurium (.7 microgram/kg BW) immediately followed by four hours of transportation). Individual calf weights were taken weekly and feed consumption recorded. Blood samples were taken at 0, 8, and 22 hours postinjection. Inclusion of EIF seed decreased (P < .05) calf weight gain (17 vs. 10 SE 1 kg), average daily gain (.76 vs. .37 SE .1 kg/d), and overall feed intake (4.8 vs. 4.0 SE .2 kg/d). Blood characteristics were not affected (P > .5) by an interaction between main effects. However, stress increased (P < .07) blood concentrations of white blood cells 22 hours after injection (10,500 vs. 18,450 SE 2380 cells/microliter), hemoglobin (109 vs. 119 SE 2.4 mg/ml), hematocrit (30.3 vs. 32.4 SE .8 %) , and prolactin (6.6 vs. 14.9 SE 1.6 ng/ml). These data indicate that EIF seed and stress decrease animal performance. However, we did not detect an interaction between bacterial and transportation stress and ingestion of endophyte-infected fescue seed. Fescue toxicosis has been studied for many years with limited success in producing an effective and efficient treatment. Our objective was to determine effects of ivermectin, and an immune challenge on steer physiological responses and performance while consuming endophyteinfected tall fescue hay. Crossbred steers (n = 64; 308 SE 9 kg BW) were allotted to treatment by a complete randomized block design with a 2x2 factorial arrangement of treatments. Main effects were: ivermectin slow-release bolus (yes or no) and a lipopolysaccharide (Salmonella typhimurium .7 microgram/kg BW) immune challenge (yes or no). Four steers were placed in each of 16 pens and fed a dietary supplement (.45 kg/d per steer; coccidiastat and mineral supplement in a corn carrier) and ad libitium endophyteinfected tall fescue hay. Steer weights, feed consumption, and hematology were collected weekly. Data were analyzed with pen as the experimental unit. Average daily gain and feed intake were decreased (P < .1) for steers receiving both an ivermectin bolus and immune challenge when compared with steers receiving no bolus and immune challenge, and no bolus no immune challenge. Treating steers with an ivermectin slow-release bolus increased (P < .05) red blood cell counts (9,369 vs. 8,702 SE 2223 cells/microliter), hematocrit (32.5 vs. 31.0 SE .8 %), and hemoglobin (121 vs. 115 SE 3 mg/ml). Prolactin (8.3 SE 1.5 ng/ml) and leptin (2.6 SE .13 ng/ml) were not (P > .6) altered by either treatment. Serum alkaline phosphatase and cholesterol were not (P > .6) altered by either treatment; however, lactate dehydrogenase and triglycerides were altered (P < .05) by ivermectin bolus and immune challenge. These data suggest that ivermectin bolus may improve performance of cattle grazing endophyte-infected fescue by altering blood cell function. A total of 36 pigs (25,8ñ 2.0 days, 7.8ñ 1.0 kg) were used to determine the effect of composition of liquid milk replacer at a low energy level on the small intestinal permeability after weaning. Pigs were allocated to three treatments with 12 piglets per treatment. The difference in three milk replacers is the ratio of lactose and protein, a high protein content is accompanied with a low lactose content (and vice versa). In the high protein diet, the control diet and the high lactose diet, the protein content was respectively 448.6, 299.5 and 150,3 g/kg of liquid milk replacer. The lactose content was respectively 73.5, 235.0 and 400.5 g/kg. The percentage of fat was in all compositions the same: 300 g/kg. The piglets were fed restricted to simulate the low feed intake after weaning. The average energy intake at day 1 till 4 was respectively 137.3, 350.0, 416.0 and 414.0 kJ DE/kg 0.75 (std: 76.3, 105.8, 78.3, 97.7) . No creep feed was provided during the suckling period. The piglets were housed individually in transparent plastic cages, so they had visible contact. At 1, 2 or 4 days after weaning the pigs were sampled at 3,5 m distal of the Ligament of Treitz, under general anaesthesia. Permeability coefficient (10 −6 cm/s) was measured by Ussing chambre. Transcellular transport was measured by Gly-Sar, paracellular transport was measured by Mannitol. At a low energy level, the milk replacer with a high ratio of lactose / protein had a tendency to have less paracellular transport then the control diet (P<0.10). Compared to day 1, day 2 and 4 had significant increased paracellular transport (P<0.05). The ratio between trans-and paracellular transport was significantly increased for the milk replacer with the high ratio lactose / protein compared to the control (P<0.05). In conclusion, the ratio between lactose / protein can influence the transepithelial transport. CLA alters body composition when fed to growing animals. This study investigated effects of CLA fed during gestation and lactation on the growth and development of piglets. Sows were fed a control diet containing corn and soybean meal with 0.83% soy oil (n=8) or a 0.5% CLA diet containing corn and soybean meal supplemented with 0.83% CLA-60, Conlinco (n=6) from day 40 of gestation through weaning (day 28). Within 24 hours of birth (day 0), one male and one female piglet per litter were sacrificed. Body and organ weights recorded and tissue samples were frozen. Weights of remaining pigs were recorded on day 0, 7, 14, 21 and 28. Blood was collected on day 0 and 28. Two barrows and two gilts per litter were weaned onto a corn and soybean meal based diet until market weight. Animals were weighed 69 days post-weaning, and loin eye area and backfat thickness were determined 133 days postweaning. Sow's milk samples were collected on day 21 of lactation and fatty acid composition was determined using gas chromatography. Leptin concentrations of pigs' serum (days 0, 28) and sow's milk (day 21) were determined via RIA (Linco). CLA did not alter sow's feed intake, body weight, backfat thickness, or litter size and weight at birth (P>0.05). CLA resulted in significant decreases in newborn pig heart, kidney, and lung weights, but not backfat weight relative to their body weights (day 0). Body weight and gain were decreased on day 7, 14 (P<0.05) however, this effect was not significant at weaning (P>0.05). There was no difference in either weight or weight gain post-weaning. There were no differences in serum leptin on day 0 and day 28 or in sows' milk on day 21 (P>0.05). CLA decreased total milk fat by 17% (P<0.01) and caused significant changes in the amounts of specific fatty acids resulting in an increase in % saturated fatty acids and a decrease in % unsaturated fatty acids in milk from day 21 of lactation (P<0.05). In Utero Dietary CLA alters body composition in newborn pigs by altering organ weight, not backfat. Changes in subsequent growth rates until day 14 may be due to changes in the sow's milk composition since growth rate and body weight did not differ post-weaning. This effect may be of significance when feeding CLA and in helping to determine CLA's mechanisms of action. The lactating sow limits the growth potential of the neonatal pig by limiting the supply of nutrients and/or not providing the optimum balance of nutrients to maximize growth. Therefore, alterations in sow milk composition could improve piglet weight gains. Fifty-five mixed parity lactating sows (Landrace x Chester White) were blocked by parity and randomly assigned to receive either a corn-soybean meal diet (control) or a diet with 1% CLA-60 (conjugated linoleic acid, ConLinCo Inc. Detroit Lakes, MN). Diets were formulated to meet the nutrient requirements of a high producing lactating sow (NRC, 1998) and sows were fed to appetite. Treatments were initiated at approximately 4 d postfarrowing and continued until weaning at 22 d of lactation. Sow weights and backfat measurements were taken initially and again at weaning. Pig weights and sow milk samples were collected initially, 7 d post treatment, and again at weaning. The inclusion of CLA did not alter sow ADFI, ending litter weights (average 60.9±1.0 kg) or litter size (average 10.3±.1 pigs/litter), sow weight or backfat losses (P > .20). Milk samples from sows fed the CLA had a lower percentage of total solids (P < .05), fat (P < .01), and tended to have lower gross energy content (P < .10), but were not different in protein or ash content (P > .20). Milk samples from sows fed CLA had greater C12:0, C14:0, C16:0 (P < .01), and tended to have greater C18:0 concentrations (P < .10). However, sows that received CLA had milk with lower concentrations of C18:1 (P < .05), C18:2 (P < .01), and tended to have lower concentrations of C14:1 (P < .10), but were not different in C16:1 (P > .10) or C18:3 (P > .20) concentrations. These results suggest that sow milk fat content can be reduced with the dietary addition of CLA, but this did not result in any differences in piglet growth rate. Three hundred (200 entire boars, 100 barrows) pigs were used in a 2x3 factorial design to assess the efficacy of a gonadotrophin releasing hormone (GnRH) vaccine, Improvac r , in eliminating boar taint. The respective factors were sex (barrows (BA), boars treated with placebo (EB) or boars treated with Improvac (IB)) and slaughter age (23 (E) or 26 wks (L)). Vaccines (2 ml) were administered 8 and 4 wks before slaughter. All IB exhibited anti-GnRH titres. Testes (467 vs 219 g) and bulbourethral gland (142 vs 64 g) weights were reduced (P<.001) and serum testosterone were below 2 nM in the majority of IB (94% and 92% at 2 and 4 wks post secondary vaccination, respectively Sixteen individually-penned entire male pigs were used in study to investigate the interactions between commercial immunocastration vaccine (Improvac r ) and porcine somatotropin (pST, Reporcin r ) regimes.
The study was a 2x2 factorial design with the respective factors being immunocastration vaccine (unvaccinated or 2 ml of Improvac r at 14 and 18 weeks of age) and pST (0 or 5 mg/d from 18 weeks of age until slaughter). Pigs were individually-penned and fed ad libitum until slaughter at 22 weeks of age. Chemical indicators of boar taint, androstenone (AEN) and skatole (SKA) were measured in fat samples by HPLC. As shown in the table below, while neither Improvac r or Reporcin r alone had any effect upon daily gain, the combined treatment increased daily gain by 25%. Feed intake was decreased by pST treatment but simultaneous treatment with Improvac r ameliorated the reduction in feed intake. FCR was not affected by Improvac r , but was reduced by pST treatment. Improvac r dramatically decreased testes size and the level of both boar taint compounds in fat whereas pST had no effect upon testes weight or fat SKA but reduced fat AEN. For fat AEN, the effects of pST and Improvac r were additive. In conclusion, Improvac r and Reporcin r have synergistic effects upon growth rate in individually-penned boars. The effect of Paylean on swine growth performance was evaluated from 1983 to 1993 in 20 dose titration trials involving 1,922 pigs. Barrows and gilts were fed 16% crude protein diets containing 0, 5, 10, or 20 ppm Paylean from approximately 67 kg to approximately 105 kg body weight. All growth performance data were taken after a 0-d Paylean withdrawal. Results showed that Paylean increased rate of weight gain (P<0.01) and improved feed to gain ratio (P<0.01) at all doses evaluated. In 13 of the 20 dose trials, carcass data were taken after either a 0-d, 4-d, or 5-d withdrawal period. Dressing percent was increased at 5 ppm (P<0.05), and at 10 and 20 ppm (P<0.01). Loin eye area was increased (P<0.01) for all doses and fat-depth at the tenth rib was decreased (P<0.01) for the 10 and 20 ppm doses. Color, firmness, and marbling of the longissimus dorsi were not affected (P>0.05) by any Paylean dose. Percentage dissected lean from the pork carcass was increased at the 5 ppm dose (P<0.05) and at the 10 and 20 ppm doses (P<0.01). Percent lean cuts (trimmed, boneless), determined only for the 20 ppm dose, were increased (P<0.01). In conclusion, Paylean fed at 5, 10, or 20 ppm improves swine growth performance and increases carcass leanness without affecting meat quality factors. Zebra Fish (Brachydanio rerio) and other tropical fish, such as Giant Danios (Danio aequipinnatus), are often used as a model for growth development, molecular genetics, and immunology. Their small size is often a limitation in these studies. To address this, a 14-week growth study was initiated to determine the effects of recombinant bovine somatotropin (rbST; 5.0% dilution of Posilac) on growth performance and size; where Giant Danios (mean weight 2.87 ± 0.20 g) were allotted to two treatment groups with five replicates. Treatments were shaminjected controls (C) and 120 mg/g BW rbST (T). Fish were reared in 10 gal aquariums with individual filter systems at 27
• C, and were hand fed twice daily to satiation. A high fishmeal commercial trout diet (55% crude protein) was used to provide for maximum growth. The fish received one intraperitoneal injection every 21 days starting on d 0. Fish were weighed weekly for 98 days. Resulting weights for d 28, 63, and 98 were 3.14, 3.50, and 3.86 g for C and 4.90, 7.41, and 8.86 g for T.
Recombinant bST treatment increased (P < 0.0001) growth rates 538% throughout d 98, where total gain for C was 1.11 g and T was 5.99 g. The final weight of group T (8.86 g) was 129% greater (P < 0.0001) than group C (3.86 g). A similar study was conducted with Zebra Fish (mean weight 0.435 ± 0.05 g), using the same treatment groups. The resulting weights for d 14, 28, 42, and 56 were 0.479, 0.508, 0.568, and 0.575 g for C and 0.573, 0.569, 0.630, and 0.610 g for T. The initial 2 week growth response to rbST was maintained throughout d 56, with the lack of continued response possibly due to higher maturity level of the fish at the time of the trial. Administration of rbST can greatly increase the growth rates of Giant Danios, and was shown to have a short-term effect on adult Zebra Fish.
Key Words: Somatotropin, Giant Danio, Zebra Fish
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Effects of replacing fish meal protein with meat and bone meal protein as a major dietary ingredient on growth performance in rainbow trout (Oncorhynchus mykiss). G.T. Schelling*, M.T. Casten, N.J. Hughes, R.A. Roeder, and R.W. Hardy, University of Idaho, Moscow.
Feeding experiments were conducted to examine the potential of replacing fish meal protein (FM) with a standard, good quality meat and bone meal protein (MBM) in 25% increments for growing rainbow trout. With the objective of making an overall evaluation of growth performance and carcass composition, semi-purified diets were used to provide FM protein:MBM protein of 100:0, 75:25, 50:50, 25:75, and 0:100 as the sole dietary protein in isonitrogenous and isocaloric diets. Two hundred and twenty five rainbow trout (mean weight 120 g) were alloted to five treatments with three replicates in a randomized block design. The tanks were five cubic feet; water flow = 20.51 L/min; temperature = 15
• C.
The fish were hand fed to satiation twice daily and were weighed on d 0, 21, 42, and 63. Daily gain, daily feed intake, and feed/gain ratios were determined for growth performance. A sub-population of fish were sacrificed on d 63 for body composition determination by whole carcass proximate analysis. In the 100:0 diet, fish gained 3.8 g/d and the relative percentage gains for the series of diets with increasing MBM protein were 100, 90, 83, 85, and 59% (59 lower, P < .05). The feed/gain ratios were .94, .98, 1.04, 1.09 and 1.46 (1.46 less efficient, P < .05), respectively. There were no marked differences (P > .05) in dry matter and protein content of the whole body carcass fed the dietary treatments. The 0:100 diet resulted in reduced growth (P < .05) and therefore, had somewhat more carcass fat (P < .05). This work indicates that FM protein in semi-purified diets for rainbow trout can be replaced with 25 and 50% MBM protein with only 5 and 10% loss in F/G, and even up to 75% with a 15% loss in F/G. 
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Growth response of white sturgeon to bovine somatotropin dosage levels and administration patterns. G.T. Schelling*, M.T. Casten, R.A. Roeder, and R.W. Hardy, University of Idaho, Moscow.
The slow growth of white sturgeon (Acipenser transmontanus) results in low production and propagation, and we previously reported a considerable growth increase when they were administered 80 µg bST/g body weight of bovine somatotropin (bST). It is the objective of this work to determine growth responses with 0 (C), 40 (L), 80 (M), and 120 (H) µg bST/g body weight (Posilac) administered intraperitoneally at 3 wk and 15 wk intervals. The sturgeon (initial wt. 1100 g) were grown in raceways that held 16
• C water, and were fed a commercial trout diet. At the end of the 272 d trial, the C,L,M, and H treated fish weighed 2752, 4735, 5599, and 5706 g. The table shows the 6 wk period gains for the treatments that were administered at the first eight 3 wk intervals (first four 6 wk periods) and then terminated. The table reveals a considerable growth response (262%) average) for the L, M, and H treatments at 3 wk intervals. The last column in the table demonstrates that during the last 6 wks of the 15 wk injection, the L period response dropped to that of C. However, both the M and H treatments were still producing a significant (P <.05) growth response. This work demonstrates the tremendous growth response that occurs when white sturgeon are administered bST. The low bST level provided for maximal gain when administered at 3 wk intervals, but higher dosage levels were required to maintain high gains over the 15 wk administration interval. 
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Growth response of rainbow trout to bovine somatotropin dosage levels and administration patterns. G.T. Schelling*, N.J. Hughes, P.R. Simpson, and B.C. Peterson, University of Idaho, Moscow, ID / USA.
A five-week growth study with juvenile rainbow trout administered a sustained-release bovine somatotropin (bST as Posilac r ) was conducted to determine the effect of administration level and frequency on growth performance. The study was designed to evaluate the efficacy and efficiency of the sustained deliver system for fish. The treatments were: (C) control, (10/W)10 µg bST/g BW/weekly, (20/W) 20 µg bST/g BW/weekly, and (120/3W) 120 µg bST/g BW/3 wks. Each treatment consisted of 3 replicate tanks of 5 fish having an initial weight of 16 g. The fish were grown in 15
• C water and were hand-fed daily to satiety.
A commercial high-fishmeal trout diet was used that contained 57% protein and met the recognized nutrient requirements. The fish were handled weekly for weighing and treatment, and all non-injected fish received a weekly needle puncture. The 5-wk gains for the fish were: 17.4, 32.1 30.3 and 29.3 g/fish for the C, 10/W, 20/W and 120/3W treatments. All of the bST treatments resulted in increased gains (P < .01) of similar magnitude (P > .05). The average bST gain response over the controls was 75.9%. The F:G for the 4 treatments were 4.57, 3.11, 2.98 and 3.20, respectively. The average F:G improvement (P < .05) was 32.3%. The feed intake for the 4 treatments was 3.0, 4.2, 3.6 and 3.9 g/fish/week respectively, and was increased (P < .05) by all bST treatments by 30.0%. Previous work in this laboratory demonstrated that 120 µg/g BW at 3 wk injection intervals was needed for maximal gain. Since the 10 µg bST/g BW/wk treatment resulted in the same growth performance as the 120 µg bST/g BW/3-wk period, there is at least approximately a 4-fold increase for bST by using the 3-wk injection frequency. The current work indicates that while the delivery system is efficacious for at least 3 wks, the efficiency is decreased relative to weekly administrations. Muscle satellite cells are myogenic cells, which are critically important for postnatal muscle growth. The insulin-like growth factors (IGFs) are believed to play an important role in satellite cell growth and development and the biological activity of the IGFs is regulated by a family of IGFBPs. Other growth factors, which affect satellite cell growth, may work in part through the IGF-IGFBP system. We have reported previously that IGFBP-3 and -5 are produced specifically by porcine satellite cells (PSC) but not by muscle derived fibroblasts isolated from these primary cultures. The objective of this study was to determine the basal expression levels of IGFBP-3 and -5 steady-state mRNA levels in PSC cultures. IGFBP-3 and -5 mRNA were measured using ribonuclease protection assays (RPAs) using procine-specific IGFBP-3 and -5 probes. PSC were isolated from the hind limb muscle of 7 wk old crossbred pigs, plated on reduced growth factor matigel 1:100 v/v)-coated plates. Proliferating cultures of PSC in control media or exposed to growth factors for 18 hr were harvested and total RNA was extracted. Both IGFBP-3 and -5 mRNA are expressed by primary PSC cultures. IGFBP-5 mRNA expression level is significantly higher in these cultures than IGFBP-3 mRNA. These data indicate that PSC produce IGFBP-3 and -5 mRNA and that steady-state IGFBP-5 mRNA levels are higher than those of IGFBP-3 in these cultures. Ribonuclease protection assays were used to measure the steady-state level of IGF-I mRNA in the semimembranosus muscles and livers of steers implanted from 32 to 38 d with Revalor-S, a combined trenbolone acetate and estradiol implant. Steady-state IGF-I mRNA levels were 73% higher (P<.01, n=7) in the livers of implanted steers than in the livers of nonimplanted, control steers. Similarly, steady-state IGF-I mRNA levels were 47% higher (P<.01, n=7) in the semimembranosus muscles of implanted steers than in the same muscles from nonimplanted, control steers. Steady-state hepatocyte growth factor and myostatin mRNA levels were not different in the semimembranosus muscles of implanted and nonimplanted steers. Circulating IGF-I concentration was 40% higher (P<.01, n=7) in implanted steers than in nonimplanted, control steers. Additionally, the number of actively proliferating satellite cells that could be isolated from the semimembranosus muscle was 45% higher (P<.01, n=7) in implanted steers than for nonimplanted steers. Viewed together these data suggest that elevated muscle IGF-I levels stimulate increased satellite cell proliferation that may contribute to the increased muscle growth observed in Revalor-S-implanted steers. We have reported that glucocorticoids can induce premature differentiation of GH-secreting cells both in vitro and in vivo during chicken embryonic development.
In the present study, the mechanism of glucocorticoid-induced GH gene expression was assessed using quantitative in situ hybridization analysis for GH mRNA directly in cell culture plates. Values presented below are in counts per minute (cpm) from 32 P labeled GH riboprobe recovered after posthybridization washes. Embryonic day twelve (e12) pituitary cells were cultured for 48 hours in the presence of vehicle (VEH), GH-releasing hormone (GHRH) at 100 nM, CORT at 1 nM and GHRH plus CORT in combination. Steady state levels of GH mRNA were significantly affected by treatment (60 ± 6, 218 ± 13, 1720 ± 35 and 10499 ± 371 cpm for VEH, GHRH, CORT and GHRH plus CORT, respectively; P<.0001). In a second experiment, e12 cells were cultured in plates and treated for 0, 8, 16, 24 and 48 h with CORT at 1 nM. Duration of treatment with CORT significantly affected levels of GH mRNA (73 ± 6, 465 ± 16, 1224 ± 29, 2144 ± 42 and 1785 ± 35 cpm for 0, 8, 16, 24 and 48 h, respectively; P<.0001). In a third set of experiments, e12 cells were cultured for 12 h in the presence of VEH, CORT at 1 nM , CORT at 1 nM plus cycloheximide (CHX) at 5 µM and CHX at 5 µM. Treatment with CHX significantly blocked the induction of GH mRNA by CORT (173 ± 18, 1500 ± 60, 242 ± 32 and 68 ± 12 cpm for VEH, CORT, CORT plus CHX and CHX, respectively; P<.0001). Culture of e12 cells in the presence of CHX at 5 µM for 12 h followed by new medium with CORT at 1nM for 12h resulted in a substantial increase in GH mRNA, indicating that the substantial reduction in responsiveness to CORT in the presence of CHX observed was not due to non-specific toxic effects. We conclude that induction of GH mRNA by corticosterone in chicken fetal pituitary cells is mediated by a protein(s) synthesized in response to corticosterone. To gain insight into the molecular mechanisms of skeletal muscle development, we searched for genes regulated by the differentiation of C2C12 myogenic cells. The differentiation of skeletal muscle starts when mononucleated myoblasts (MB) withdraw from the cell division cycle, align, elongate, and fuse into multinucleated myotubes (MT). Using Differential Display PCR (dd-PCR) in C2C12 myogenic cells, we tested the hypothesis that the differentiation of MB to form MT is accompanied by significant changes in gene expression. C2C12 cells were grown to 80-90% confluency in DMEM +10% fetal bovine serum. Differentiation was induced by the addition of DMEM + 2% horse serum + 10 uM cytosine arabinoside. Total RNA was extracted from 6 culture plates (3 containing MB, 3 containing MT). cDNA from these samples was used as template for dd-PCR, providing three replicates within treatment. Bands were excised based on the consistency of banding within replicates (cell state) versus differences across cell type. To date, 100 primer combinations (5 anchor (3) x 20 arbitrary (5)) have been used to identify over 100 putative differentially expressed bands. Preliminary sequencing results from four of these bands yielded homologies to Myosin Light Chain-2, AMP deaminase 3, and Glutathione Peroxidase 1. Northern hybridization will be used to confirm differences observed in gene expression from the dd-PCR results. In the past it has been impossible to examine a large array of changes during this critical step in muscle growth. Differential Display PCR has allowed us to observe many differences in gene expression between two treatments (differentiated (MT), undifferentiated (MB)) in C2C12 myogenic cells.
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The effect of LXRα activators on adipocyte differentiation. T The objective of this study was to investigate a potential role for LXRα, a ligand-activated orphan receptor expressed in adipose tissue, in regulating adipocyte differentiation. 3T3-L1 preadipocytes were used to examine the effect of treatment with known activators of LXRα [22(R)-hydroxycholesterol (22R), 20(S)-hydroxycholesterol (20S)] on adipocyte differentiation. Cells were seeded at a density of 3 x 10 4 cells/cm 3 on sixwell (35-mm) tissue culture plates in 2 mL of DMEM medium plus 10% fetal bovine serum and were maintained at 37 • C in a 5% CO2-humidified environment. Cells were grown to confluence (d 2). On d 0, differentiation was induced by treatment with insulin (10 µg/mL), dexamethasome (1 mM), and IBMX (.5 mM). Cells were treated with either ligand or carrier (ETOH) from d 0 to d 7. In separate experiments, 22R or 20S was administered at concentrations of 2.5, 5, 10, or 20 µM. Cholesterol (Chol), which does not appreciably activate LXRα, was administered at concentrations of 2.5, 10 or 20 µM. Differentiation was evaluated by measuring sn-glycerol-3-phosphate dehydrogenase (GPDH; EC 1.1.1.8) activity on d 7. Independent experiments were performed on duplicate wells where n=3 for 22R and n=2 for both 20S and Chol. Protein content was determined by the Bradford method using bovine serum albumin as a standard. Compared to controls, 22R reduced GPDH activity (nmol/(min*mg protein) by 20% at 5 µM (p<.05) and 40% at both 10 and 20 µM (p<.01). Administration of 20S did not affect GPDH activity at 5 µM (p<.08) and 10 µM (p<.19) while significantly decreasing GPDH at 20 µM (89%, p<.01). However, 20S appeared to affect cell viability at 20 µM. Cholesterol administration did not have any effect on GPDH activity at any concentration examined. These data suggest the LXRα receptor may play an important role in inhibition of adipocyte differentiation. Identifying genetic markers pertaining to specific traits for growth and carcass quality would be a substantial benefit to the beef industry. The present study was undertaken to test for differential gene expression in intramuscular adipocytes during fat deposition of feedlot steers. Angus X Hereford steers (n=50) that were fed a high-energy concentrate ration ad libitum for 20 (n=5), 86 (n=15), 121 (n=15) and 146 (n=15) d to obtain various developmental stages of marbling. Subcutaneous fat measurements at slaughter averaged 0.18", 0.29", 0.43" and 0.53" (P<.05), respectively. Carcass traits were statistically different (P<.05) between days on feed. Intramuscular adipose was excised from the longissimus dorsi, snap frozen in liquid nitrogen and stored at -80
• C. Total cellular RNA was extracted with TRIzol and Dnased. RNA concentrations were normalized and pooled. Pooled samples of total RNA (2 µg) representing each day on feed were then analyzed by differential-display polyamide chain reaction (DD-PCR), using 200 primer combinations comprised of 20 arbitrary (5') and 10 anchor (3') oligonucleotides. Band differences among treatment groups were scored and 70 bands of interest were harvested. Excised bands were reamplified by PCR, sequenced and submitted to GenBank for homology identification. Mouse mammary epithelial cells(NMuMG cells) were incubated by the addition of 17β-estradiol(1nM, E)+progesterone(10nM, P) or E+P+EGF with or without various types of oligomers(21-mer) to EGF receptor activity domain(cDNA:+711-+731). Sense or antisense oligomers were encapsulated in protein A-bearing liposome. Uncoupled protein A and unencapsulated sense or antisense oligomers were separated from liposomes on Sepharose 4B columns(encapsulation efficiency of oligomers in liposome-protein A; 0.8%). Addition of E+P into various concentration of EGF showed the interaction in DNA synthesis between EGF and E+P(P≤0.05). Antisense oligomers 1µM decreased DNA synthesis induced by E+P or E+P+EGF(53.4 or 65.6% inhibition to control, P≤0.05). Sense oligomers(1µM) also inhibited DNA synthesis induced by E+P or E+P+EGF(P≤0.05). However, random-sequenced oligomers(21-mer, 1µM) did not inhibit EGF-induced DNA synthesis. The inhibitory effect of sense oligomers should be due to the unexpected match to functional gene product in growth. Cells were bound with keratin monoclonal antibody(5µg/ml) and then incubated with dilution of protein A-bearing liposomes containing sense or antisense oligomers in the presence of E+P or E+P+EGF. Dose dependent inhibition of DNA synthesis was observed. In the presence of E+P+EGF, 10 or 100nM encapsulated antisense oligomers in liposome-protein A inhibited DNA synthesis by 71.2 or 78.9% to control, respectively(P≤0.05). The encapsulated oligomers in liposome-protein A inhibited DNA synthesis at 100 fold lower concentration than the unencapsulated oligomers. Incubation with keratin monoclonal antibody increased uptake of oligomers by mammary epithelial cells for 6 hour incubation compared to those without keratin monoclonal antibody, however keratin monoclonal antibody effect was moderate in inhibition of DNA synthesis.
Key Words: Mammary, EGF receptor gene, Liposome
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The effect of glucagon and insulin on β-oxidation of 1-14 C-palmitate by piglet hepatocytes in primary culture. G. Matsey*, X. Lin, and J. The litter size has been one of important economic traits in pig reproduction. Insulin-like growth factor-I (IGF-I) has been shown to mediate actions of steroid hormone or synergize with other endocrine factors so that it consequently plays roles in reproductive processes, including ovulation, implantation, maintenance of pregnancy, and fetal development. But, the effect of serum IGF-I on porcine litter size has not been studied much. Therefore, this study was conducted to relate serum estradiol (E2), progesterone (P4), IGF-I concentration, and IGF binding protein (IGFBP)-3 expression with porcine litter size. Moreover, the possible association with estrogen receptor (ER) as a candidate gene for the litter size was investigate. Sera from estrous cycle to postnatal growth were colleceted from pigs in two groups showing high and low litter sizes. Serum E2,, P4, and IGF-I concentration were measured by RIA and IGFBP-3 expression was detected by ligand blotting. DNA extracted from blood was utilized for PCR-RFLP to analyze ER genotypes of pigs in each group, which produced three polymorphic patterns. During estrous cycle, IGF-I and P4 concentration in both groups decreased from metestrus to estrus, but IGFBP-3 and E2 showed opposite expressions. Also, IGF-I and IGFBP-3 concentration decreased gradually as pregnancy proceeded. Unlike E2 and P4, IGF-I and IGFBP-3 decreased moderately as new born pigs grew. Significant differences in IGF-I amount between two groups were partially detected at metesterus (P<0.001), day 40 (P<0.05) of pregnancy, and day 30 (P<0.05) of postnatal growth. Furthermore, based on the ER genotype analyzed, low litter size group showed higher IGF-I concentration than high litter size group during the pregnancy and postnatal growth. Taken together, the results indicate that the serum IGF-I was correlated with steroid hormones system but not intimately with litter size in pigs. But, if the expression of IGF-I and IGFBP-3 were examined together with ER genotype, it is possible to utilize IGF-I as a probe for predicting the litter size in pigs. Thus, this study implies that porcine litter size might be affected by IGF-I through a mechanism acting locally at the ovary.
Key Words: Pig, IGF-I(Insulin-like Growth Factor-I), Litter Size
606
Quantification of bovine liver pyruvte carboxylase and phosphoenolpyruvate carboxykinase mRNA by Northern blot analysis. C. Agca* and S.S. Donkin, Purdue University, West Lafayette, IN. Pyruvate carboxylase (PC; EC 6.4.1.1) and phosphoenolpyruvate carboxykinase (PEPCK; EC 4.1.1.32) are two rate limiting enzymes for gluconeogenesis. These enzymes are regulated, at least in part for bovine, through changes in mRNA abundance. Northern blot analysis provides data for relative differences between samples for a specific mRNA, but fails to provide quantative information between two different mRNA species. In order to overcome this limitation, 1050 bases of bovine PC and 1150 bases of bovine cytosolic PEPCK were cloned into transcription vectors. Plasmids containing PEPCK and PC inserts were linearized, and sense cRNA strands were synthesized and quantified. Total RNA (20 µg) from liver biopsy samples from 7 cows on -28 and +1 day relative to calving were separated by agarose gel electrophoresis. The electrophoresis was interrupted and 12, 25, 50, 100, 200, and 400 pg of PEPCK cRNA and 1. 5, 3, 6, 12, 25, 50 , and 100 pg of PC cRNA were added to the sample wells and the electrophoresis was continued. The RNA was transferred to Genescreen membrane, which was hybridized sequentially with 32 P labeled PEPCK and PC cDNAs. The abundance of mRNA (pg/µg total RNA) between samples taken on -28 and +1 days relative to calving is similar for PEPCK (17.3 ± 6.6 and 15.5 ± 6.7). However PC mRNA abundance is higher (P < 0.05) on +1 day (1.9 ± 1.1) compared to -28 day relative to calving (0.5 ± 0.2). The PEPCK to PC mRNA (pg/pg) ratio is diminished (P < 0.05) between -28 and +1 days relative to calving (35.2 ± 18.4 vs. 8.8 ± 3.8). This method provides quantitative information combined with the simplicity of Northern blot analysis to enable a direct comparison of changes in expression of PC and PEPCK mRNA. Results point to large differences between absolute quantities of PEPCK and PC mRNA. The relative quantities of these mRNA, assuming similar translational efficiencies, indicate that an increase in PC can contribute to increased gluconeogenesis from pyruvate at calving despite a lack of change in PEPCK.
Key Words: Pyruvate carboxylase, Phosphoenolpyruvate carboxykinase, Gene expression
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Cloning of bovine hepatic cytosolic and mitochondrial phosphoenolpyruvate carboxykinase mRNA and expression in bovine liver. C. Agca*, R.B. Greenfield, and S.S. Donkin, Purdue University, West Lafayette, IN.
Phoshoenolpyruvate carboxykinase (PEPCK; EC 4.1.1.32) is compartmentalized in the cytosol and mitochondria and these forms are encoded by two different genes. Ruminant liver contains approximately equal activities of mitochondrial PEPCK (PEPCK-M) and cytosolic PEPCK (PEPCK-C). Our objective was to clone the two forms of bovine PEPCK cDNA and determine their expression in liver before and after calving. Regions of identity for human, rat, and mouse PEPCK-C and mouse and human PEPCK-M mRNA were used to design primers for reverse transcriptase-PCR. The 5' and 3' rapid amplification of cDNA ends protocol was used to clone the 5' and 3' ends of PEPCK-C and 3' end of PEPCK-M mRNA. The PCR products of PEPCK-C and PEPCK-M were ligated to pGEM 3Z plasmid and sequenced. Bovine PEPCK-C mRNA contains 2592 nucleotides, and encodes 622 amino acid. The cDNA coding sequence of bovine and human PEPCK-C show 84% identity. A partial clone of the 3' end of PEPCK-M contains 460 bases. The PEPCK-M clone is 76% identical to the corresponding human sequence. The coding sequence of bovine PEPCK-C is 54% identical to bovine PEPCK-M with negligible identities of 3' untranslated region. The 3' end clones were chosen as cDNA probes due to sequence differences. Total RNA from liver biopsy samples obtained from 10 cows at -28, -14, +1, +14, and +56 relative to calving were used for Northern blot analysis of PEPCK-C and PEPCK-M. Northern blot analysis shows that both PEPCK-C and PEPCK-M mRNA are approximately 2.5 kb. The correlation coefficient of PEPCK-C and PEPCK-M is 0.54. The mRNA PEPCK-C is increased (P<0.05) at 28 days after calving yet the abundance of PEPCK-M is unchanged during this period. The ratio of PEPCK-C to PEPCK-M is increased (P<0.05) during this interval. Because PEPCK-M provides 50% of the total PEPCK activity in ruminants, it may play an important role in gluconeogenesis yet PEPCK-M mRNA does not appear to be specifically regulated during the transition to calving.
Key Words: Gene expression, Compartmentalization, Phoshoenolpyruvate carboxykinase
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The somatotropic axis of young calves can be modulated by nutrition and bST. A.L. Bork*, J.M. Smith, M.R. Foote, and M.E. Van Amburgh, Cornell University, Ithaca, NY.
Our objective was to investigate the responsiveness of the somatotropic axis in young calves. We hypothesized that young calves provided a higher plane of nutrition would express improved growth rates, higher insulin-like growth factor-I (IGF-I) levels, and a greater response to bST treatment. Nineteen neonatal Holstein bull calves were randomly assigned to one of two treatment groups at an average age of 4.2 d (week one) and fed milk replacer (MR) until nine weeks of age. Treatment (TRT) 1 calves were fed MR containing 20% crude protein (CP), 20% fat at a rate of 1.4% body weight (BW) dry matter (DM) per day. Calves assigned to TRT 2 were fed a 30% CP, 20% fat MR at a rate of 2.4% BW DM per day. Calves were weighed weekly on two consecutive days and DM intake was adjusted accordingly. At five weeks of age, on three consecutive days, all calves were given a daily injection of bST (120 µg/kg BW). Blood samples were obtained every Tuesday and immediately prior to first bST injection and 14 and 24 hours after the third injection. Plasma samples were later analyzed for IGF-I by radioimmunoassay after glycyl-glycine extraction. Average growth rates for calves assigned to TRT 1 and TRT 2 were 0.44 and 1.10 kg/day (P< 0.001), respectively. From week two to week nine of life, calves assigned to TRT 2 had higher circulating IGF-I levels compared to TRT 1, (128.5ng/ml vs. 73.3 ng/ml for TRT 2 and 1, respectively (P < 0.001)), consistent with the higher energy and protein intake. Calves on both treatments responded similarly to the bST challenge (40% increase in circulating IGF-I levels). Surprisingly, however, calves assigned to TRT 2 exhibited a 460 g/d increase in growth rate for the seven day period following bST challenge with no change in intake. Calves assigned to TRT 1 did not exhibit a change in growth rate. We conclude that the somatotropic axis is functioning in young calves, and that calves on a high plane of nutrition are not only able to respond to a bST challenge with higher IGF-I, but also exhibit a growth response at five weeks of age.
Key Words: Calves, Nutrition, IGF-I
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Thyroid hormones regulate somatotroph abundance during chicken embryonic development. L. Liu* and T. E. Porter, University of Maryland, College Park.
We reported previously that corticosterone can induce somatotroph differentiation in vitro and in vivo and that triiodothyronine (T3) can act synergistically with corticosterone to further augment the abundance of somatotrophs in vitro. The objective of the present study was to test our hypothesis that thyroid hormones regulate the abundance of somatotrophs during chick embryonic development. First, we tested if administration of T3 to developing chick embryos could increase somatotroph proportions prematurely in vivo. Somatotroph differentiation normally occurs between embryonic day 12 (e12) and e16. The albumen of fertile eggs was injected on e11 with T3 (12 pg, 120 pg, 1.2 ng). The embryos were then allowed to continue developing until e13, when pituitary cells were isolated and subjected to reverse hemolytic plaque assays and immunocytochemistry to detect GH-secreting and GH-containing cells, respectively. Injection of T3 increased GH-secreting cells to 7.6±0.7% (12 pg of T3) and 8.4±0.6% (120 pg of T3) of all pituitary cells (P<0.05), compared to 3.8±0.6% for basal levels. The 1.2 ng dose of T3 was ineffective. The percentage of GH-containing cells was increased from the control level of 4.6±0.9% to 7.4±0.9%, 9.4±0.9% and 12.6±0.9% by 12 pg, 120 pg and 1.2ng of T3, respectively (P<0.05). Next, we evaluated the effects of the thyroid hormone synthesis inhibitor methimazole on somatotroph differentiation during development. Injection of 5 µg of methimazole on e9 decreased the abundance of GH-containing cells on e14 from 13.7±0.5% for vehicle treated embryos to 7.8±0.5% (P<0.05). Taken together, these results indicate that treatment with exogenous thyroid hormones can modulate somatotroph differentiation and that endogenous thyroid hormone synthesis may contribute to normal somatotroph differentiation. Since we reported that T3 alone was ineffective in vitro, we interpret these findings to indicate that effects of treatments in vivo were due to interactions with endogenous glucocorticoids.
Key Words: Somatotroph, Triiodothyronine, Methimazole
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Effects of recombinant bovine somatotropin (rbST) and nutrition on growth and muscle fiber profiles in early-weaned beef steers. K. E. Moulton* 1 , T. G. We demonstrated previously that messenger RNA levels for the beta subunit of thyroid stimulating hormone (TSHβ) are maximal on embryonic day (e) 19 in chickens. However, little is known about the production of TSHβ protein in this species. The present study used a heterologous antiserum to rat TSHβ to determine the location and abundance of TSHβ producing cells during embryonic development. Western blot analysis was performed to determine the specificity of the rat TSHβ antiserum against the chicken protein. Rat TSH (10 ng), affinity purified chicken LH and FSH (1 µg each), and homogenates of chicken pituitary, liver, heart, and spleen (5 µg of protein each) were separated on a 16% SDS-PAGE gel and transferred to a nitrocellulose membrane, which was probed with the rat TSHβ antiserum. Identical peptide bands (about 17 and 30 kDa) were detected in both the rat TSH and the chicken pituitary samples. No bands were seen in the LH, FSH, or other tissue extract samples, supporting the specificity of the antiserum for chicken TSHβ. Thyrotrophs were localized in whole mount preparations of e19 pituitaries both by immunocytochemistry (ICC) using the rat TSHβ antiserum and by in situ hybridization (ISH) using a digoxigenin-labeled antisense riboprobe to chicken TSHβ. Both ICC and ISH localized thyrotrophs to the cephalic lobe of the anterior pituitary. Next, ICC was performed on dissociated pituitary cells to define the ontogeny of thyrotrophs during development. Pituitaries from e11-19 embryos and day 1 posthatch chickens were isolated, dispersed by trypsin digestion, and subjected to TSHβ ICC. TSHβ cells comprised 0.7 ± 0.1%, 4.0 ± 0.4%, 5.3 ± 0.4%, 7.0 ± 0.8%, 6.7 ± 0.7%, and 3.9 ± 0.4% of all pituitary cells on e11, e13, e15, e17, e19, and d1, respectively. Thus, thyrotrophs were rare on e11, and their abundance was maximal on e17 (P<0.01, n=4 separate trials). We conclude that TSHβ-producing cells are located in the cephalic lobe of the anterior pituitary and that the size of the thyrotroph population increases prior to hatching.
Key Words: Thyrotroph, Chicken Embryo, Development
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Partial feed restriction induces pyruvate carboxylase mRNA but not phosphoenolpyruvate carboxykinase mRNA in liver of lactating dairy cattle. J.C. Velez* and S.S. Donkin, Purdue University, West Lafayette, IN.
The ability of dairy cattle to adapt to changes in nutrient intake requires appropriate changes in expression of several key genes in liver. We determined effects of partial feed restriction on expression of pyruvate carboxylase (PC), phosphoenolpyruvate carboxykinase (PEPCK), growth hormone receptor (GHR), and insulin-like growth factor-I (IGF-I) mRNA. Six mid-lactation Holstein cows were fed a total mixed diet for ad libitum intake during a 6-day period. Liver biopsy and blood samples were obtained at the end of the period and cows were then restricted to 50% of ad libitum intake for 5 days. Liver biopsy and blood samples were obtained at the end of the second 5-d period and cows were readjusted to ad libitum intake. Liver biopsy samples were also obtained after 12-d of realimentation. Plasma non-esterified fatty acids (µM) were unchanged (235 vs. 252; ad libitum vs. feed restriction) by feed restriction. Northern blot analysis of total RNA revealed a tendency (P<.15) for increased expression of PC mRNA during feed restriction. Expression of PEPCK, GHR and IGF-I remained unchanged during this period. Expression of PC and IGF-I were elevated (P<.05) by 68% and 356% respectively during realimentation compared with the ad libitum feeding period but there were no differences for PEPCK or GHR mRNA. The lack of coordinated changes in PC and PEPCK mRNA suggests expression of these enzymes that is mediated by separate signals in bovine liver. The data also demonstrates compensatory overexpression of PC and IGF-I mRNA as a consequence of feed restriction and realimentation. Thirty-two female crossbred pigs (initial weight 75 kg) were utilised in this experiment to investigate the effect of differing porcine somatotropin (pST) regimes on growth performance. Pigs were kept in individual pens and fed ad libitum a wheat-based diet formulated to contain 14.4 MJ DE/kg and 180 g ideal protein/kg. Treatments were daily injection with saline (Sal), daily injection with pST (5 mg) (D), bidaily injection of pST (10 mg) (2D) and injection of pST (12 mg) every Monday, Wednesday and Friday (MWF) for 3 weeks. On the days that pigs were not receiving pST they were injected with saline (0.5 ml). pST treatment had no significant effect upon ADG, despite being 100 g/d greater in the 2D and MWF pigs. All pST regimes caused a reduction in feed intake and FCR. Feed intake decreased after the first injection and for the D group remained low and constant. Feed intake for the 2D group was also reduced but not to as great an extent as in the D group. Feed intake in the MWF group showed a clear temporal response with feed intake being low during the week but increasing over the latter part of the weekend. Thus, feed intake on Sunday through Monday was 400 g greater (P<.001) that on Saturday through Sunday. Therefore, it appears that the effects of pST may be reduced when a 3d interval is used between injections. P2 back fat was significantly reduced with all pST injection regimes. Alternative pST injection regimes can improve growth performance in finisher pigs. Our objectives in the current study were (1) to compare the responses to repeated ST challenges during the weaning period, and (2) to compare the response to ST challenge between heifer and bull calves. Calves received 4 L colostrum initially, then were fed a 30% CP: 20% fat milk replacer (MR) twice daily (MR DM at 2% of BW per d) and free choice water. Calves were weighed weekly and feed amounts adjusted accordingly. Calves were first offered starter (26.5% CP, 1.07 Mcal NEg/kg, DM basis) after reaching 100 kg BW. When starter was introduced, MR DM was offered at 1% BW per d for one week, then at 0.5% BW per d for one week before being discontinued. Blood was collected from three heifer and three bull calves during three 24-hr periods following bST challenges. The challenge protocol consisted of injecting 120µg/kg BW bST once daily for three days. The first bST challenge was performed when calves weighed about 105 kg. Two wk later, which was 10d after starter was first offered and MR restricted, the second bST challenge was performed. The third bST challenge took place two wk after the second challenge and 10 d after calves had been totally weaned off milk replacer. Blood was collected prior to the first bST injection (-72 hr) and at 0, 4, 8, 12, 14, 16, 18, 20, 22 , and 24 hr after the third injection. Plasma aliquots were stored at -20
• C until analyzed for IGF-1 by RIA.
Growth rates for the heifers and bulls during the period encompassing the challenges were not significantly different (P = .18), averaging 0.97 and 1.11 kg/d, respectively. Circulating IGF-1 at -72 hr was not different (P = .61) between heifer and bull calves. For all calves the response to challenge, calculated as the difference between the 14-hr post-challenge value and the -72-hr value, was not different (P = .902) among the three periods before, during, and after weaning, but was greater in heifers than bulls (P = .038). We conclude that weaning does not necessarily lead to uncoupling of the somatotropic axis and that it is reasonable to apply data derived from milk replacer-fed bull calves to heifers. Volume measurements of body regions were accomplished within three different magnetic resonance imaging (MRI) experiments on totally 96 pigs from 10 to 60 kg (MRI I: n=28, MRI II: n=22) and from 30 to 90 kg (MRI III: n=46). The purpose was to evaluate the accuracy of MRI for predicting the chemical carcass composition (MRI II, MRI III), and the dissected weights of separate muscles or fat tissues (MRI I). The MRI was performed on a Picker Vista 1.5 Tesla whole body magnet generating successive axial images with a slice thickness of 1 cm. The images were processed by means of a digitizing tablet using the Sigma Plot PC3D program for MRI I and MRI II, and by means of the 'Analyze' software (Mayo Foundation) for MRI III. The whole volumes of both longissimus dorsi muscles (MLD), the overlying fat (BF), and ham muscles were quantified in MRI I and MRI II. In experiment MRI III, the volume of both MLD and of the overlying fat was measured in a defined 10 cm section and the volume of the ham with overlying fat in a defined 15 cm section. A stepwise regression analysis was performed, estimating carcass lipid % (CLipid%) and carcass lean % (CLean%, sum of carcass protein % and water %) from volumes of MRI II and MRI III. A higher accuracy in estimating body composition resulted from a body weight range of 30 -90 kg compared to 10 -60 kg due to a very low variation in the pigs < 20 kg. However, the correlations (r) between the dissected weights and MRI volumes of specific tissue groups are very high in the weight range of 10-60 kg, e.g., with r=0.967 for MLD and r=0.973 for BF in MRI I. Dietary trimethylglycine (betaine, BET) is associated with reduced carcass fat in the growing pig. We explored potential effects of BET on fatty acid oxidation and metabolism during intravenous infusion of 1-13 C-palmitate (PA). Pigs (55 kg BW, n=6) were fed one of three diets containing 0% BET (control), 0.125% BET or 0.5% BET at 80% of ad libitum energy intake. Diets were corn-soybean meal-based and contained 17.6% crude protein and 3.27 Mcal ME/kg; experimental diets were fed for one week before initiation of infusion studies. Animals were catheterized to allow for simultaneous sampling and infusion. PA was complexed to methyl-β-cyclodextrin (MBC) for intravenous infusion. After priming the pigs with 13 C-bicarbonate, the PA/MBC complex was infused into pigs under steady-state fed conditions for 4 h at 0.7 µmol/kg/h. The control and 0.5% BET pigs were also studied under fasted conditions (n=5). Metabolism and oxidation of infused PA were determined by breath or blood 13 CO2-enrichments. CO2 (IRMS) and palmitate (GCMS) isotopic enrichments were determined by mass spectrometry. Under steady-state fed conditions, palmitate oxidation was 0.163±0.14, 0.144±0.030, 0.163±0.034 µmol/kg/min for control, 0.125% BET, and 0.5% BET pigs, respectively; dietary treatment had no effect on oxidation (P>0.1). Fasting increased overall oxidation rates by 7-8 fold in both the control and 0.5% BET groups (P<0.01), but fasting oxidation rates were similar (P>0.1) between these dietary treatment groups. Under these experimental conditions, dietary BET had no apparent effect on whole body fatty acid oxidation either in the fed or fasted state and therefore the reduction in adipose accretion must be via another mechanism. Supported in part by Finnfeeds Intl. Dietary betaine (BET) is associated with decreased lipid deposition and altered protein utilization in pigs. Recent reports have suggested that substantial positive effects of BET on feed efficiency are greater in energy-restricted pigs. The purpose of this study was to examine the effects of BET on growth and body composition in young feed-restricted pigs. Thirty-two Landrace x York barrows (36 kg, n=8 pigs per group) were fed one of four corn-soybean meal-skim milk based diets containing 0, 1.25, 2.5 or 5g/kg BET. Pigs were fed at 73% ad libitum (ARC) and feed allotment was adjusted weekly according to body wt. At 64 kg, pigs were electro-stunned, exsanguinated and organs were removed and weighed. Carcasses were chilled for 24 h at 4C to obtain carcass measurements. Fat depths along the midline and at P1, P2, P3 sites at 10 th rib were determined. One half of each carcass and total viscera (VIS) were ground for chemical analysis (H2O, fat, protein, and ash). ADG was 475, 472, 501 and 499 g/d (PSE=23) for pigs consuming 0, 1.25, 2.5 or 5g/kg BET, respectively. Compared to controls, pigs consuming .5% BET had 9.8% less carcass fat, (481 vs 434 g/kg DW, PSE=20, P<0.05); fat depth at P3 was 26% lower in .5% BET pigs (P<0.08). Carcass protein: fat ratio was 0.96 for controls and 1.13 for .5% BET pigs (PSE=.09, P<0.10) and carcass protein deposition rate was enhanced by 17% (P<0.10) in .5%BET pigs, compared to controls. Linear regression analysis indicated a positive linear association between BET level and carcass lean gain efficiency (P<0.13) while negative linear trends for small intestine wt (P<0.11) and total VIS wt (P<0.13) were noted. These data suggest that BET alters nutrient partitioning in feed-restricted pigs such that protein deposition is enhanced at the apparent expense of carcass fat and in part, VIS tissue. The current trend in the production of market pigs places emphasis on lean tissue growth rate. However, it is unclear how high lean growth rate impacts sexual development of gilts. One hundred sixty-eight prepubertal Genex Manor hybrid F1 gilts were used to examine the effect of lean growth rate on the attainment of puberty. At approximately 96 d of age and 54 kg weight, gilts were allocated with respect to growth rate and litter origin to one of two dietary treatments: 1) a diet formulated to optimize lean growth rate (O; n=84) 2) a diet producing normal lean growth rate (N; n=84). All gilts were fed treatment diets ad libitum and housed in groups of six. Weight, backfat and loin depth, and feed intake were measured weekly. Starting at 134.7 ± .26 d (mean ± sem) of age, gilts received 20 min direct exposure to a vasectomized boar daily as a pen group for pubertal stimulation. Puberty attainment was determined as the day gilts first exhibited the standing reflex in response to contact with a boar. At pubertal estrus, body weight, backfat and loin depths were recorded. Diet affected (P≤.05) weight (O, 73.7 ± .3 ; N, 71.2 ± .3 kg), growth rate (O, .63 ± .002; N, .61 ± .003 kg/d), loin depth (O, 44.0 ± .3; N, 41.7 ± .3 mm), fat depth (O, 12.3 ± .2; N, 11.6 ± .2 mm) and estimated lean growth rate (O, .37 ± .003; N, .35 ± .003 kg/d) during the growth period (start to stimulation). Feed consumed over the growth period differed (P≤.10) (O, 2.5 ± .05; N, 2.6 ± .05). Of the 160 gilts completing the trial, only five did not reach puberty by 200 d. Diet did not affect age at puberty (O, 158.6 ± 2.0; N, 158.5 ± 2.0)
